Home › Funds › Capital Impact Advisors, LLC › EXEL
Capital Impact Advisors, LLC position in EXEL
EXELIXIS INC · Health Care
Capital Impact Advisors, LLC reported holding 287,555 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$16.8M, representing 1.45% of its reported portfolio and ranking #27 among its reported holdings. Capital Impact Advisors, LLC has disclosed EXEL holdings in 8 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Capital Impact Advisors, LLC's EXEL position evolved
Capital Impact Advisors, LLC first disclosed a stake in EXEL in Q1 2024 at 42,909 shares (US$1.0M). The position peaked in Q4 2025 at 1,094,466 shares, worth US$48.0M. Across 8 filings, Capital Impact Advisors, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 287,555 shares valued at US$16.8M — a reduction of -467,109 shares quarter over quarter.. Notable position changes include a 441% increase in Q4 2025 (shares fell 3% over the following quarter), a 84% trim in Q1 2026 (shares rose 28% over the following quarter), a 340% increase in Q2 2026 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 42.91K | $1.02M | New |
| Q1 2025 | 201.61K | $7.44M | New |
| Q2 2025 | 175.55K | $7.81M | Reduce |
| Q3 2025 | 202.31K | $8.36M | Add |
| Q4 2025 | 1.09M | $47.97M | Add |
| Q1 2026 | 171.48K | $7.35M | Reduce |
| Q2 2026 | 754.66K | $41.06M | Add |
| Q3 2026 | 287.56K | $16.80M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EXEL and 13F data
EXEL (EXELIXIS INC) is a Health Care company. 41 other funds we track also report a position in EXEL — the largest reported positions include Renaissance Technologies (US$747.2M), Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EXEL
- Renaissance Technologies 12.79M sh · $747.22M · Q3 2026
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.47M sh · $732.79M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 8.93M sh · $485.85M · Q2 2026
- D. E. Shaw & Co., Inc. 5.55M sh · $302.07M · Q2 2026
- Two Sigma Investments 4.21M sh · $229.06M · Q2 2026
- Stephens Investment Management Group LLC 2.60M sh · $151.65M · Q3 2026
- Caligan Partners LP 1.55M sh · $84.51M · Q2 2026
More on Capital Impact Advisors, LLC
FAQ
How long has Capital Impact Advisors, LLC held EXEL?
Capital Impact Advisors, LLC has disclosed EXEL holdings in 8 of the last 11 reported quarters, going back to Q1 2024.
What is Capital Impact Advisors, LLC's current position in EXEL?
As of Q3 2026, Capital Impact Advisors, LLC holds 287.56K shares of EXEL (EXELIXIS INC), valued at $16.80M, representing 1.45% of its reported portfolio and ranking #27.
Has Capital Impact Advisors, LLC been buying or selling EXEL?
In the latest 13F filing (Q3 2026), Capital Impact Advisors, LLC reduced its position in EXEL. The position peaked in Q4 2025 at 1.09M shares.
Which other funds hold EXEL?
Other major institutional holders of EXEL include Renaissance Technologies, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.